Aciclovir Safety During Pregnancy: Clinical Evidence
MHRA Pregnancy Classification and Safety Data
The Medicines and Healthcare products Regulatory Agency (MHRA) classifies aciclovir as pregnancy category B, indicating animal studies show no harm and human data suggests safety when clinical benefits justify use. Extensive pregnancy registries involving over 1,200 women taking aciclovir during first trimester show no increased risk of major birth defects compared to general population rates.
Common Side Effects and Pregnancy Considerations
Standard aciclovir side effects may feel more pronounced during pregnancy due to existing symptoms. Common reactions include nausea (affecting up to 7% of users), headache, dizziness, and fatigue. Gastrointestinal upset may worsen morning sickness, while headaches might require paracetamol rather than ibuprofen for relief. Rare but serious side effects include kidney problems - pregnant women should maintain adequate hydration and report unusual symptoms immediately.
Treatment Options During Pregnancy
EverydayMeds offers several pregnancy-appropriate options including Aciclovir 400mg Tablets for oral treatment and Aciclovir 5% Cream for topical application. Topical treatment presents minimal systemic absorption, making it preferred for localised cold sores. Oral aciclovir may be recommended for severe outbreaks or suppressive therapy in late pregnancy to reduce transmission risk during delivery. Valaciclovir tablets represent an alternative with similar safety profile but improved dosing convenience.
Monitoring and Clinical Management
Pregnant women using aciclovir require standard prenatal monitoring with attention to kidney function if using high doses or extended treatment courses. Healthcare providers typically recommend starting treatment within 72 hours of symptom onset for maximum effectiveness. Suppressive therapy might be considered from 36 weeks gestation in women with recurrent genital herpes to reduce cesarean delivery risk.
